Skip to main content
NewslettersWatchlist

Journey Medical Corp(DERM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low3.40
Day High3.64
Open:3.51
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Globe Newswire
Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Globe Newswire
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity
Globe Newswire
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference
AccessWire
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
Globe Newswire
Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Globe Newswire
Journey Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022
Globe Newswire
Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
Globe Newswire
Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
Globe Newswire
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update on March 23, 2022
Globe Newswire
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea
Globe Newswire
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
Globe Newswire
Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.
Globe Newswire
Journey Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
Globe Newswire
Journey Medical Corporation to Present at the Benzinga Global Small Cap Conference
Globe Newswire
Journey Medical Corporation Announces Closing of Initial Public Offering

Profile

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.